Article

CI431, an Aqueous Compound from Ciona intestinalis L., Induces Apoptosis through a Mitochondria-Mediated Pathway in Human Hepatocellular Carcinoma Cells

Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
Evidence-based Complementary and Alternative Medicine (Impact Factor: 1.88). 07/2011; 2011:292873. DOI: 10.1155/2011/292873
Source: PubMed

ABSTRACT In the present studies, a novel compound with potent anti-tumor activity from Ciona intestinalis L. was purified by acetone fractionation, ultrafiltration, gel chromatography and High Performance Liquid Chromatography. The molecular weight of the highly purified compound, designated CI431, was 431Da as determined by HPLC-MS analysis. CI431 exhibited significant cytotoxicity to several cancer cell types. However, only a slight inhibitory effect was found when treating the benign human liver cell line BEL-7702 with the compound. To explore its mechanism against hepatocellular carcinoma, BEL-7402 cells were treated with CI431 in vitro. We found that CI431 induced apoptotic death in BEL-7402 cells in a dose- and time-dependent manner. Cell cycle analysis demonstrated that CI431 caused cell cycle arrest at the G2/M phase, and a sub-G1 peak appeared after 24 h. The mitochondrial-mediated pathway was implicated in this CI431-induced apoptosis as evidenced by the disruption of mitochondrial membrane potential. The results suggest that the CI431 induces apoptosis in BEL-7402 human hepatoma cells by intrinsic mitochondrial pathway.

0 Followers
 · 
158 Views
 · 
8 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Xiaoaiping, extracted from Marsdenia tenacissima (Asclepiadaceae), is a Chinese medicine used to treat cough and asthma. Previous studies have shown that its active ingredients possess anti-inflammatory and anticancer effects. The aim of this study was to investigate the antitumor activities of Xiaoaiping through apoptosis induction in human gastric cancer SGC-7901 cells. The MTT assay was used to assess the cell growth and cell viability. SGC-7901 cells were treated with Xiaoaiping injection [(20–40) mg·mL−1] for 24 and 48 h. The apoptotic cells and the cell cycle distribution were analyzed by flow cytometry. The in vivo activity of Xiaoaiping was determined by the growth inhibition of the established tumor xenografts in nude mice. Caspase-3 activity, Bax and Bcl-2 proteins in tumor tissue were measured by immunohistochemistry and apoptosis was assayed by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) method. Xiaoaiping inhibited SGC-7901 cell growth in a time and dose dependent-manner and the estimated IC50 was (38.20 ± 0.27) mg·mL−1 after 24 h of treatment. The body weight and the tumor volume were significantly reduced in nude mice bearing human gastric tumor treated with Xiaoaiping. The inhibition rate of tumor growth in the mid-dose (200 mg·kg−1) group and high dose (400 mg·kg−1) group were 61.19% and 69.07%, respectively. Immunohistochemical staining showed an increase in caspase-3 and Bax expression whereas Bcl-2 expression decreased gradually. Xiaoaiping exerted potent antitumor activity in vitro and in vivo against human SGC-7901 cells; induced apoptosis and G1 cell cycle arrest. These results suggest that Xiaoaiping is a promising antitumor agent for the treatment of human gastric cancer.
    Chinese Journal of Natural Medicines 09/2012; 10(5):339–346. DOI:10.1016/S1875-5364(12)60068-5